© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
October 08, 2010
Safety and adverse event monitoring don't stop when a vaccine is approved.
Investigators face several technical, logistical, and cultural challenges when conducting vaccine trials in developing nations.
Although the market is growing, vaccine makers face a variety of technical, research, and business challenges.
October 07, 2010
Virus-like particles have been used in approved vaccines and several prophylactic and therapeutic vaccine candidates in clinical development.
Heather Woolery-Lloyd, MD, FAAD: Interview on Common Skin of Color Dermatoses
Orit Markowitz, MD: Artificial Intelligence, Patient Knowledge on Skin Cancer
Ruxolitinib Cream Improves Atopic Dermatitis Pain, Anxiety and Depression Over 52 Weeks